Cecal, colonic, and fecal samples from isogenic controls WT and Rag
mice, as well as the colitic RagT group (6 mice per group, 18 total) were
collected on day 56 for metabolome extraction and liquid chromatography-mass
spectrometry untargeted metabolomics analysis. Following data analysis, features
were prioritized for MS/MS experiments, metabolite identification, and
differential analysis to find altered levels of molecules in RagT colitis
samples. A panel of metabolites with significantly altered levels in IBD, and no
prior known role in this disease, were profiled in cell-based assays that can
reveal pro-inflammatory and anti-inflammatory properties.